Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMD“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate

Approved? Not-approved? What is “tentative approval?” Clinical trial data on this novel “once nightly” sodium oxibate showed the drug to be acceptable for narcolepsy. But legal issues are holding up the FDA approval process.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form